EUR · 5 valued
€1.07 million
Supplier · public contract awards
Octapharma GmbH public contracts.
Octapharma GmbH has won 37 public contracts between 2020 and 2026 from 9 public buyers in Germany. Its most frequent buyer is AOK Bayern - Die Gesundheitskasse (8 awards). Outside TED, published values total €1.07 million across 5 awards. 19 awards were published on TED; the median contract size is about €210,000 (5 contracts with a value).
37Contracts won
9Public buyers
1Country
Mar 2026Latest award
Latest contracts won
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben / Blutprodukte zum 1.Januar 2026
Awarded by Pbmg Eg · Germany
2 Mar 2026Awarded
Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu Arzneimitteln zur Behandlung der Hämophilie
Awarded by AOK Sachsen - Anhalt · Germany
31 Aug 2023Awarded
Ex-post-Transparenzbekanntmachung Vertrag gem. § 130a iVm 130c SGB V (Blutgerinnungsfaktor IX & VIII (human)_Simoctocog alfa_Von Willebrand-Faktor_Oct
Awarded by AOK Nordost - Die Gesundheitskasse · Germany
29 Jul 2023Awarded
Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Octapharma GmbH zu Nuwiq(
Awarded by IKK classic · Germany
2 Jul 2021Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130c SGB V Nuwiq (Simoctocog alfa); Octanate (Faktor VIII); Octanine F (Faktor IX); Wilate (Von Wille
Awarded by AOK Nordost – Die Gesundheitskasse · Germany
1 Oct 2020Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130c SGB V Afstyla (Lonoctocog alfa); Beriate (Blutgerinnungsfaktor VIII); Voncento (Von Willebrand-F
Awarded by AOK Nordost – Die Gesundheitskasse · Germany
1 Oct 2020Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130c SGB V Simoctocog alfa
Awarded by AOK Bayern – Die Gesundheitskasse · Germany
30 Sep 2020Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 SGB V von Willebrand-Faktor und Blutgerinnungsfaktor VIII in Kombination (Handelsname: Wi
Awarded by AOK Bayern — Die Gesundheitskasse · Germany
30 Sep 2020Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 SGB V Blutgerinnungsfaktor VIII (Handelsname: Octanate (R))
Awarded by AOK Bayern – Die Gesundheitskasse · Germany
30 Sep 2020Awarded
Ex-Ante-Transparenzbekanntmachung Vertrag gem. § 130a Abs. 8 SGB V Blutgerinnungsfaktor IX (Handelsname: Octanine F (R))
Awarded by AOK Bayern – Die Gesundheitskasse · Germany
30 Sep 2020Awarded
Contracts won by year
Contracts won by year
from the published recordsPublished value, by currency (feeds other than TED)
Typical contract size on TED
EUR · median of 5 contracts
€210,000
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against Octapharma GmbH?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding See open tenders